Cargando…
A pan‐cancer atlas of cancer hallmark‐associated candidate driver lncRNAs
Substantial cancer genome sequencing efforts have discovered many important driver genes contributing to tumorigenesis. However, very little is known about the genetic alterations of long non‐coding RNAs (lncRNAs) in cancer. Thus, there is a need for systematic surveys of driver lncRNAs. Through int...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210054/ https://www.ncbi.nlm.nih.gov/pubmed/30216655 http://dx.doi.org/10.1002/1878-0261.12381 |
_version_ | 1783367029919580160 |
---|---|
author | Deng, Yulan Luo, Shangyi Zhang, Xinxin Zou, Chaoxia Yuan, Huating Liao, Gaoming Xu, Liwen Deng, Chunyu Lan, Yujia Zhao, Tingting Gao, Xu Xiao, Yun Li, Xia |
author_facet | Deng, Yulan Luo, Shangyi Zhang, Xinxin Zou, Chaoxia Yuan, Huating Liao, Gaoming Xu, Liwen Deng, Chunyu Lan, Yujia Zhao, Tingting Gao, Xu Xiao, Yun Li, Xia |
author_sort | Deng, Yulan |
collection | PubMed |
description | Substantial cancer genome sequencing efforts have discovered many important driver genes contributing to tumorigenesis. However, very little is known about the genetic alterations of long non‐coding RNAs (lncRNAs) in cancer. Thus, there is a need for systematic surveys of driver lncRNAs. Through integrative analysis of 5918 tumors across 11 cancer types, we revealed that lncRNAs have undergone dramatic genomic alterations, many of which are mutually exclusive with well‐known cancer genes. Using the hypothesis of functional redundancy of mutual exclusivity, we developed a computational framework to identify driver lncRNAs associated with different cancer hallmarks. Applying it to pan‐cancer data, we identified 378 candidate driver lncRNAs whose genomic features highly resemble the known cancer driver genes (e.g. high conservation and early replication). We further validated the candidate driver lncRNAs involved in ‘Tissue Invasion and Metastasis’ in lung adenocarcinoma and breast cancer, and also highlighted their potential roles in improving clinical outcomes. In summary, we have generated a comprehensive landscape of cancer candidate driver lncRNAs that could act as a starting point for future functional explorations, as well as the identification of biomarkers and lncRNA‐based target therapy. |
format | Online Article Text |
id | pubmed-6210054 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-62100542018-11-08 A pan‐cancer atlas of cancer hallmark‐associated candidate driver lncRNAs Deng, Yulan Luo, Shangyi Zhang, Xinxin Zou, Chaoxia Yuan, Huating Liao, Gaoming Xu, Liwen Deng, Chunyu Lan, Yujia Zhao, Tingting Gao, Xu Xiao, Yun Li, Xia Mol Oncol Research Articles Substantial cancer genome sequencing efforts have discovered many important driver genes contributing to tumorigenesis. However, very little is known about the genetic alterations of long non‐coding RNAs (lncRNAs) in cancer. Thus, there is a need for systematic surveys of driver lncRNAs. Through integrative analysis of 5918 tumors across 11 cancer types, we revealed that lncRNAs have undergone dramatic genomic alterations, many of which are mutually exclusive with well‐known cancer genes. Using the hypothesis of functional redundancy of mutual exclusivity, we developed a computational framework to identify driver lncRNAs associated with different cancer hallmarks. Applying it to pan‐cancer data, we identified 378 candidate driver lncRNAs whose genomic features highly resemble the known cancer driver genes (e.g. high conservation and early replication). We further validated the candidate driver lncRNAs involved in ‘Tissue Invasion and Metastasis’ in lung adenocarcinoma and breast cancer, and also highlighted their potential roles in improving clinical outcomes. In summary, we have generated a comprehensive landscape of cancer candidate driver lncRNAs that could act as a starting point for future functional explorations, as well as the identification of biomarkers and lncRNA‐based target therapy. John Wiley and Sons Inc. 2018-10-02 2018-11 /pmc/articles/PMC6210054/ /pubmed/30216655 http://dx.doi.org/10.1002/1878-0261.12381 Text en © 2018 The Authors. Published by FEBS Press and John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Deng, Yulan Luo, Shangyi Zhang, Xinxin Zou, Chaoxia Yuan, Huating Liao, Gaoming Xu, Liwen Deng, Chunyu Lan, Yujia Zhao, Tingting Gao, Xu Xiao, Yun Li, Xia A pan‐cancer atlas of cancer hallmark‐associated candidate driver lncRNAs |
title | A pan‐cancer atlas of cancer hallmark‐associated candidate driver lncRNAs |
title_full | A pan‐cancer atlas of cancer hallmark‐associated candidate driver lncRNAs |
title_fullStr | A pan‐cancer atlas of cancer hallmark‐associated candidate driver lncRNAs |
title_full_unstemmed | A pan‐cancer atlas of cancer hallmark‐associated candidate driver lncRNAs |
title_short | A pan‐cancer atlas of cancer hallmark‐associated candidate driver lncRNAs |
title_sort | pan‐cancer atlas of cancer hallmark‐associated candidate driver lncrnas |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210054/ https://www.ncbi.nlm.nih.gov/pubmed/30216655 http://dx.doi.org/10.1002/1878-0261.12381 |
work_keys_str_mv | AT dengyulan apancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas AT luoshangyi apancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas AT zhangxinxin apancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas AT zouchaoxia apancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas AT yuanhuating apancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas AT liaogaoming apancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas AT xuliwen apancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas AT dengchunyu apancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas AT lanyujia apancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas AT zhaotingting apancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas AT gaoxu apancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas AT xiaoyun apancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas AT lixia apancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas AT dengyulan pancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas AT luoshangyi pancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas AT zhangxinxin pancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas AT zouchaoxia pancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas AT yuanhuating pancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas AT liaogaoming pancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas AT xuliwen pancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas AT dengchunyu pancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas AT lanyujia pancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas AT zhaotingting pancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas AT gaoxu pancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas AT xiaoyun pancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas AT lixia pancanceratlasofcancerhallmarkassociatedcandidatedriverlncrnas |